Professor, School of Pharmaceutical Sciences, Southwest University, Chongqing, China
Professional Experience
2014-2017 Distinguished Chair Professor of Neuroscience and Pharmacology, Guangdong Ocean University, China
2009-2012 Assistant Professor of Pharmacology, Tulane University Medical School, New Orleans, LA, USA
2008-2009 Assistant Professor of Physiology, Georgetown University Medical School, Washington DC, USA
2005-2008 Post-doctoral Research Fellow, National Institute of Mental Health, Bethesda, USA
2003-2005 Researcher, Medical School, Tampere University, Tampere, Finland
1996-2003 Director of Research, Centre for Physiology and Biochemical Research, Kiev, Ukraine
1996 Visiting Academic Scientist, University of Birmingham Medical School, Birmingham, UK
1995 Academic Researcher, Bristol University Medical School, Bristol, UK
Education & Training
1989-1996 BS/MS in Physiology (Summa Cum Laude), Moscow State University, Russia
2003 PhD in Physiology, RUDN State University, Moscow, Russia
2003-2005 Postdoctoral Fellow in Anatomy, Neuroscience, Tampere University Medical School, Tampere, Finland
2005 PhD in Anatomy, Tampere University, Tampere, Finland
2005-2008 Postdoctoral Research Fellow in Neuroscience and Pharmacology, NIMH/NIH, Bethesda, USA
Awards
2007-2010 NARSAD Young Investigator Award
2009-2010 Tulane-LSU Pilot CRECP Grant
2010 LA Board of Regents P-Fund grant
2011-2012 NIH/NIDA R03 SOAR Grant and supplement
2011 Tulane Pilot Grant
2012 LA BoR Opt-In II Grant
Selected Publication
Kyzar EJ, Nichols CN, Nichols D, Gainetdinov RR, Kalueff AV. Psychedelic drugs in biomedicine. Trends in Pharmacological Sciences (TIPS), 2017, in press. [IF = 10.0]
Kalueff AV, Stewart AM, Graybiel AM, Berridge KC, Fentress JC. Neurobiology of rodent self-grooming and its value for translational neuroscience research. Nature Reviews Neuroscience, 2016, 17, 45-59 [IF = 31.2]
Song C, Berridge KC, Kalueff AV. 'Stressing' rodent self-grooming for neuroscience research. Nature Reviews Neuroscience, 2016, 591-592 [IF = 31.2]
Song C, Shieh SH, Wu YS, Kalueff AV, Gaikwad S, Su KP. The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer’s disease: acting separately or synergistically? Prog Lipid Res, 2016, in press [IF = 10.02]
Stewart AM, Kalueff AV. Controlled substances and innovation of biomedicine: a preclinical perspective. Nature Reviews Neurosciences, 2013, 15, 34-35 [IF = 31.2]
Kalueff AV, Stewart AM, Gottesman I. Targeting dynamic interplay among disordered domains or endophenotypes to understand complex neuropsychiatric disorders: Translational lessons from preclinical models, Neuroscience and Biobehavioral Reviews, 2015, 53:25-36 [IF = 10.1]
Stewart AM, Ullmann J, Norton WJ, Parker MO, Brennan CH, Gerlai R, Kalueff AV. Molecular psychiatry of zebrafish. Molecular Psychiatry, 2015, 20, 2-17 [IF = 15.40]
Kalueff AV., Stewart AM, I Gottesman. Rethinking CNS disorders: time for new drug targets? Trends in Pharmacological Sciences (TIPS), 2014, 35, 491-492. [IF = 10.0]
Kalueff AV., Stewart AM, Gerlai R. Zebrafish as an emerging model for complex brain disorders. Trends in Pharmacological Sciences (TIPS), 2014. [IF = 10.0]
Stewart AM, Braubach O, Gerlai R, Kalueff AV. Zebrafish models for translational neuroscience research: from tank to bedside. Trends in Neurosciences TINS, 2014 [IF = 14.0]
.jpg)